Pirfenidone improves survival in IPF: results from a real-life study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pirfenidone improves survival in IPF: results from a real-life study
Authors
Keywords
-
Journal
BMC Pulmonary Medicine
Volume 18, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-23
DOI
10.1186/s12890-018-0736-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy data in treatment extension studies of idiopathic pulmonary fibrosis: interpret with caution
- (2018) Athol U Wells Lancet Respiratory Medicine
- An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP)
- (2017) Ulrich Costabel et al. RESPIRATION
- Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis
- (2017) Steven D Nathan et al. Lancet Respiratory Medicine
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis
- (2016) Gareth Hughes et al. Journal of Clinical Medicine
- An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline
- (2015) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
- (2015) John Hutchinson et al. EUROPEAN RESPIRATORY JOURNAL
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study
- (2012) Marco Mura et al. EUROPEAN RESPIRATORY JOURNAL
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Hot of the breath: Mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good
- (2012) Athol U Wells et al. THORAX
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
- Bias due to withdrawal in long-term randomised trials in COPD: Evidence from the TORCH study
- (2010) Jørgen Vestbo et al. Clinical Respiratory Journal
- Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial
- (2009) Jean-Philippe Collet et al. Archives of Cardiovascular Diseases
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started